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ABSTACT 
 The Erk/MAPK pathway plays a major role in cell growth, differentiation, and 
survival. Genetic mutations that cause dysregulation in this pathway can result in the 
development of Rasopathies, a group of several different syndromes including Noonan 
Syndrome, Costello Syndrome, and Neurofibromatosis Type-1.  Since these mutations 
are germline and affect all cell types it is hard to differentiate the role that Erk/MAPK 
plays in each cell type.  Previous research has shown that individual cell types utilize the 
Erk/MAPK pathway in different ways. For example, the morphological development of 
lower motor neuron axonal projections is Erk/MAPK-independent during embryogenesis, 
while nociceptive neuron projections require ERK/MAPK to innervate epidermal targets. 
Here, we tested whether Erk/MAPK played a role in the postnatal development of lower 
motor neurons during crucial periods of activity-dependent circuit modifications. We 
have generated Cre-dependent conditional Erk/MAPK mutant mice that exhibit either 
loss or gain of Erk/MAPK signaling specifically in ChAT:Cre expressing lower motor 
neurons. Importantly, we found that Erk/MAPK is necessary for the development of 
neuromuscular junction morphology by the second postnatal week. In contrast, we were 
unable to detect a significant difference in lower motor neuron development in 
Erk/MAPK gain-of-function mice. The data suggests that Erk/MAPK plays an important 
role in postnatal lower motor neuron development by regulating the morphological 
maturation of the neuromuscular junction.  
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CHAPTER I LITERATURE REVIEW 
 
Role of Kinases During Development 
During development, intercellular communication is crucial for the regulation of 
proper cellular differentiation and function. Cells accomplish this in part via extracellular 
polypeptide ligands that act upon receptors expressed on the cell membrane (Hubbard 
and Till, 2000). One prominent class of receptors, receptor tyrosine kinases (RTKs), are 
transmembrane glycoproteins that bind specific ligands and function to transduce 
extracellular signals that regulate cell development including proliferation, migration, 
and/or differentiation (Schlessinger and Ullrich, 1992). RTKs activate a number of 
intracellular signaling cascades that mediate a wide range of cellular behaviors including 
PI3-Kinase, PLCgamma, and ERK/Mitogen-activated protein kinases (Erk/MAPK).  
Erk/MAPKs are a highly conserved pathway that features a sequential three-tier structure 
consisting of Raf (ARAF, BRAF, CRAF), Mek (MEK1 & MEK2), and Erk (ERK1 & 
ERK2) (Krishna and Narang, 2008).  The individual tiers of the MAP Kinase pathway are 
phosphorylated, and thus activated, by upstream Ras/Rho family proteins that are 
activated by a range of external signals (Krishna and Narang, 2008). In the Erk/MAPK 
signaling pathway activated Ras leads to the phosphorylation of B/C-Raf, which in turns 
phosphorylates MEK1/2, which then phosphorylates ERK1/2. The end of this three-tier 
pathway features MAPK binding to specific targets, phosphorylating them, and activating 
substrates such as transcription factors and protein kinases (Nishimoto and Nishida, 
2006). Simply put, extracellular signals bind to the surface of the cell and triggers  
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biochemical mechanisms that alter cellular behavior.  
Four main types of MAPK signaling cascades can be found in mammals. These 
are the extracellular signal regulated kinases 1 and 2 (ERK1/2 or Erk/MAPK), 
extracellular signal regulated kinase 5 (ERK5), c-Jun N-terminal kinase (JNK), and P38 
(Newbern et al. 2011; Rauen, 2013). In the context of neurodevelopment ERK1/2 and 
ERK5 are important MAPK pathways due to their role in the regulation of cell 
proliferation and differentiation (Nishimoto and Nishida, 2006). Both pathways respond 
to similar trophic stimuli, such as nerve growth factor (NGF), and can also induce 
immediate early genes, such as c-fos and c-jun (Kamakura et al, 1999; Kato et al, 1997).  
 
Rasopathies  
The Erk/MAPK pathway has been extensively studied in the context of both 
cancer and development. Oncogenesis research has discovered that about 20% of cancer 
cases have a mutation in Ras and around 7% have a mutation in BRaf (Bos, 1989; 
Pritchard et al, 2007). Given the role of MAPK pathways in the proliferation of cells it 
makes sense that mutations in components of this pathway could lead to unregulated cell 
proliferation. Research is also being done to understand the effects of genetic mutations 
in Erk/MAPK signaling in the context of developmental biology. Developmental 
disorders known as Rasopathies contain germline mutations in genes that regulate 
Erk/MAPK signaling which can cause profound effects on the development of an  
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organism due to the organism’s early reliance on extracellular input to induce cell 
proliferation and differentiation (Rauen, 2013).  
Rasopathies are typically characterized by cutaneous abnormalities, 
musculoskeletal defects, cardiac issues, neurological problems, and a predisposition to 
various forms of cancer (Stevenson, 2012; Rauen, 2013). Patients with NF1, Costello 
syndrome, and cardio-facio cutaneous syndrome share common muscular phenotypes 
such as hypotonia and variable muscle fiber size (Tidyman et al., 2011). This results in 
weakness, gross motor delays, hypotonia, and underdeveloped muscle bulk (Tidyman et 
al., 2011). Patients with NF1 have been shown to have abnormal motor proficiency 
(Souza et al., 2009), weakness (Johnson et al., 2011), and decreased muscle area 
(Stevenson et al., 2005). Tests like the one-legged vertical jump test and hand-held 
dynamometry reveal a significant reduction in force production from NF1 patients 
(Viskochil et al., 2013). Patients with CFC syndrome have hypertonia and dysfunctional 
gait (Reinker et al., 2011). Reports of weakness and an increased density of muscle 
spindles have been found in individuals with Costello Syndrome and Noonan syndrome 
(van der Burgt et al., 2007). These data clearly indicate that the neuromuscular system 
does not develop correctly in Rasopathies.  However, whether deficits are driven by 
problems in the muscle, the nervous system, or both is not well understood. 
  
Motor Neurons 
There are two main motor neuron types that regulate muscle movement; upper 
motor neurons and lower motor neurons. The upper motor neurons originate in the motor 
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cortex and send their axons down the spinal cord where they synapse onto lower motor 
neurons. These lower motor neurons, also known as spinal motor neurons, are located 
into the ventral horn of the spinal cord and are found in the most rostral level of the 
spinal cord all the way down to the most caudal level. Lower motor neurons are 
specialized cell types that extend their axons out to the periphery, synapse onto muscle 
fibers, and ultimately function to initiate muscle contraction and movement.  
 Among these lower motor neurons are several subtypes that perform different 
functions including alpha, beta, and gamma motor neurons (Figure 1). Alpha motor 
neurons innervate large extrafusal muscle fibers and are responsible for muscular 
contraction. They are the characterized by a large cell body and their characteristic 
neuromuscular junctions. This subtype of motor neuron can be further subdivided into 
three categories depending on the type of extrafusal muscle fiber they innervate: slow-
twitch fatigue-resistant (SFR), fast-twitch fatigue-resistant (FFR), and fast-twitch 
fatigable (FF) (Burke et al, 1973). SFR lower motor neurons are the first to fire during 
muscular contraction. This is due to their higher input-resistance, a result of having a 
smaller cell body, which causes them to respond to a lower threshold of stimulation. FFR 
lower motor neurons fire second during muscular contraction. This is due to having lower 
input-resistance than SFR neurons and having higher input-resistance than FF neurons. 
FF lower motor neurons are the final subtype to fire during muscular contraction. They 
fire slowly due to having a large cell body and therefore lower input-resistance. The 
recruitment order of these neurons, from smallest to largest, during muscular contraction 
is the known as the “size principal” (Mendell, 2005). The differing properties of the alpha  
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motor neurons subtypes lead to different mean conduction velocities: 100m/s for FF and 
85m/s for SFR (Burke et al, 1973). 
Beta motor neurons innervate both extrafusal and intrafusal muscle fibers 
(Bessou, Emonet-Denand, & Laporte, 1965). This allows them to contract muscle and 
provide sensory feedback from muscle spindles. They can be further divided into two 
subtypes: static and dynamic. Static beta motor neurons innervate nuclear chain fibers 
and work to increase the firing rate of type Ia and II sensory fibers. Dynamic beta motor 
neurons innervate muscle spindle bag fibers and work to increase the stretch sensitivity of 
type Ia sensory fibers. Given their small size and lower abundance these motor neurons 
are not as well understood as the other subtypes of lower motor neurons.  
Gamma motor neurons modulate the sensitivity of muscle spindles within muscle 
fibers. They can be further subdivided into two subtypes: static and dynamic. Static 
gamma motor neurons innervate nuclear chain fibers and static nuclear bag fibers. 
Dynamic gamma motor neurons innervate dynamic nuclear chain fibers. Though the two 
subtypes of gamma motor neurons innervate different targets they both work to adjust the 
sensitivity of muscle spindles by keeping them taut. The coordinated effort between th 
sensory information coming from the muscle spindle and the motor information being 
sent to the muscle spindle allows the continued firing of alpha motor neurons and is 
important for maintaining proper sensory function of spindles during contraction (Kandel 
et al., 2015) 
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Figure 1: Motor Neuron Subtypes (Stifani, 2014) The three types of alpha motor neurons 
are alpha fast fatigable (aFF), alpha fast-twitch fatigue-resistant (aFFR), and alpha 
slow-twitch fatigue-resistant (aSFR). These alpha motor neurons innervate fast-twitch 
fatigable, fast-twitch fatigue-resistant, and slow-twitch fatigue-resistant muscle fibers. 
The gamma motor neuron is another subclass of motor neuron. It innervates the 
intrafusal bag fibers of muscle spindles. 
 
Lower Motor Neuron Development 
 The development of lower motor neurons begins when the ectoderm undergoes 
neurulation shortly after gastrulation. During neurulation, the ectoderm folds into itself 
and leads to the formation of the neural tube, neural crest cells, and the external ectoderm 
(Figure 2A-2C). From the neural tube emerges the entire CNS (Purves et al, 2011). After 
neurulation, the neural tube begins to differentiate even further into specialized spinal 
cord progenitor domains (Figure 2D). This is accomplished by several inductive signals 
that surround the neural tube.  
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Figure 2: Early Embryogenesis and Embryonic Spinal Cord. (A-C) Schematic of the 
process of neurulation (D) Schematic of the dorsoventral axis of neuronal subtypes. 
(adapted from Kandel, 2013) 
 
Dorsoventral Patterning 
The dorsoventral patterning of the spinal cord arises from inductive factors 
secreted from the overlying roof plate and ectoderm and the underlying floor plate and 
notochord. The roof plate and ectoderm secrete the inductive signals wingless-related 
integration site proteins (WNTs) and bone morphogenic proteins (BMPs) to establish a 
decreasing dorsal to ventral gradient (A. Liu & Niswander, 2005). The floorplate and  
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notochord secrete sonic hedgehog morphogen (SHH) to establish an increasing dorsal to 
ventral gradient (Briscoe & Ericson, 2001). These dorsoventral inductive signal gradients 
collaborate to repress different homeodomain transcription factors to generate unique 
neuronal progenitor domains (Figure 3). These ventral progenitor domains give rise to the 
lower motor neurons and the surrounding interneuron populations. 
 
Figure 3: Generation of The Ventral Spinal Cord Progenitor Domains.  
Schematic of the process by which inductive signals surrounding the spinal cord work to 
repress homeodomain transcription factors and form individual domains of neurons.  
(adapted from Stifani, 2014)  
 
Lower Motor Neuron Specification 
 Once the motor neuron progenitor domain has been established, further 
specification of motor neurons begins. The motor neurons of the spinal cord can be 
characterized in many different ways, including their position along the rostro-caudal 
axis, the specific muscle they innervate, which spinal column they’re found in, and 
whether they project to the dorsal or ventral side of the body (Dasen & Jessell, 2009).  
The positional identity of each motor neuron on the rostrocaudal axis is determined by  
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the coordinative effort of multiple molecular inducers. High levels of retinoic acid (RA) 
promote the differentiation of rostral motor neurons in the cervical and brachial region 
while a high level of FGF8 and Gdf11 promote the differentiation of caudal motor 
neurons in the thoracic and lumbar regions (J.-P. Liu, Laufer, & Jessell, 2001) (Figure 4).  
 
Figure 4: Rostrocaudal Inductive Factors. Schematic of the inductive factors, e.g. RA and 
FGF8, and their rostrocaudal expression (Dasen & Jessell, 2009) 
 
The molecules that establish the rostocaudal gradient and induce the specification 
of neuronal subtype identity are integrated by Hox transcription factors (Dasen & Jessell, 
2009) (Figure 5). In both the mouse and human, the Hox genes can be found on four 
chromosomal clusters that have spatial organization based on where they are expressed in 
the embryo. Hox genes that are closer to the 3’ end of the chromosome, like Hox5, are 
expressed at brachial levels whereas Hox genes closer to the 5’ end of the chromosome, 
like Hox11, are expressed at lumbar levels (Lappin, Grier, Thompson, & Halliday, 2006).  
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The specific spatial expression of different Hox genes within the spinal cord work to 
establish motor neuron pool identity and specify the type of muscle that it will eventually 
innervate (Dasen et al., 2005). 
 
  
Figure 5: Vertebrate Hox Gene Clusters 
Schematic of the four chromosomal Hox gene clusters in the mouse (adapted from 
Kandel, 2013)  
 
Axon Guidance and Synaptogenesis 
Before the motor neuron can exert any control over movement, three cells need to 
travel long distances. The first cell types are myogenic precursors that eventually form 
the muscle. Myogenic precursors from the mesoderm travel to the sites where muscles 
will form, differentiate into myoblasts, and subsequently fuse into myotubes 
(Buckingham et al., 2003) (Figure 6a-b). The myotubes line up in parallel and become  
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the muscle fibers with which neurons will synapse on to. The second cell types are the 
lower motor neurons. The lower motor neurons must send their axons out into the 
periphery in order to synapse onto muscle fibers (Figure 6a-e). This process is called 
axonal guidance and there is a rich panoply of molecular mechanisms that guide the axon 
on its long journey (Tessier-Lavigne & Goodman, 1996). The third cell types that must 
make their journey into the periphery are myelinating glia of the peripheral nervous, the 
schwann cells. Schwann cells originate from the neural crest and travel into the periphery 
to myelinate the axons of motor neurons (Woodhoo & Sommer, 2008) (Figure 6b-e). 
 
 
Figure 6 | Axon Formation, Axon Guidance, and Synaptogenesis 
(A-E) Diagram detailing the process of axon formation, axon guidance, and 
synaptogenesis (Adapted from Sanes and Lichtman, 1999)  
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Mechanisms of Axon Guidance 
 Axons are the primary structure through which neurons exert their influence over 
targets. The process of growing an axon out into the periphery requires multiple guidance 
cues that ensure the axon grows in the correct direction and synapses onto the correct 
target. The four primary forces that act to guide the axon towards its target are 
chemoattraction, chemorepulsion, contact attraction, and contact repulsion (Tessier-
Lavigne & Goodman, 1996) (Figure 7).  
Chemorepulsive forces can be demonstrated by looking at the ephrin tyrosine 
kinase receptors and their ligands. As an axon makes its way into the periphery it will 
come across specific ephrin ligands that will bind to the growth cone and repel it. For 
example if an EphA receptor expressing medial motor column (MMC) motor neuron 
axon growth cone comes into contact with EphA ligands in the dorsal root ganglia (DRG) 
the axon will be prevented from entering and begin to project dorsally (Gallarda et al., 
2008). Chemoattractive forces can be also be demonstrated with the MMC neurons. As 
mentioned before the EphA ligands prevent the axon from venturing into the DRG, but 
what is causing the axon to project dorsally? Fibroblast growth factors (FGFs) secreted 
by the dorsal epithelial cell layer, the dermomyotome, bind to the FGFR1 receptor of the 
MMC neurons and act as a chemoattractant for the axon (Shirasaki et al, 2006). These 
long-range cue signals the axon to continue traveling through the periphery, but it is 
important to note that there are several short-range cues that assist the axon on its 
journey. One example of a class of short-range cues would be the immunoglobulin cell  
adhesion molecules (Ig CAMS). Ig CAMS, such as NCAM, bind to the growing axon  
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and transduce the signaling cascade PKC that leads to actin polymerization (Li et al., 
2013). 
 
Figure 7: The Four Guidance Forces. The four forces that help guide the axon towards 
its proper target are chemorepulsive, contact repulsive, chemoattractive, and contact 
attractive (Adapted from Sanes and Lichtman, 1999)  
 
 
The Neuromuscular Junction 
 Arguably one of the most important components of a neuron is its synapse. 
Throughout the nervous system there exists many different synapses that work together to 
create functional circuits that mediate complex behaviors. One such synapse is the 
neuromuscular junction (NMJ). The NMJ is the synapse formed between lower motor 
neurons and the skeletal muscle fibers they innervate. This synapse is crucial for the  
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control of muscle contraction and the execution and coordination of movement.  
 
Acetycholine Signaling 
The motor neuron signals to the muscle by releasing the neurotransmitter 
acetylcholine. At around E10-E11 the motor neurons complete their terminal mitosis and 
begin to express a detectable amount of the enzyme responsible for the synthesis of 
acetylcholine, choline acetyltransferase (ChAT) (Chen et al, 1992). Acetylcholine is then 
packaged into vesicles and sent to the synapse (Del Castillo & Katz, 1954). Here the 
vesicles congregate at active zones awaiting the action potential that will initiate fusion 
with the membrane and the release of neurotransmitter into the synaptic cleft (Sanes & 
Lichtman, 1999).   
In order to respond to the neurotransmitter released by the motor neuron, the 
muscle fibers contain a high concentration of acetylcholine receptors (AChRs) numbering 
over 10,000/µm2 (Salpeter & Loring, 1985).  AChRs, along with voltage gated Na+ 
channels, are highly concentrated into junctional folds directly apposed to presynaptic 
active zones, thus ensuring that neurotransmitter release at the synapse will bind to the 
muscle (Flucher & Daniels, 1989).  
 
Muscle Differentiation  
 Initially, the density of AChRs embedded in the membrane are homogenously  
expressed throughout the membrane at around 1,000 per µm2 (Bevan & Steinbach, 1977). 
This drastically changes as the axon begins to make contact with the newly differentiated  
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myotube. Once the axon establishes synaptic contact with the muscle, AChRs become 
circumscribed and localized underneath the site of contact, leading to a severely 
increased intrasynaptic/extrasynaptic ratio of AChR coverage of the muscle (Bevan & 
Steinbach, 1977). Numerous molecular mediators have been identified that contribute to 
the increase in AChR grouping underneath the overlying axon. 
 
Agrin 
  Before the motor neuron synapses onto the muscle, AChRs congregate along the 
middle of the muscle fiber (Yang et al., 2001). Although this is an important first step, 
further differentiation of the NMJ requires signals from the neuron. An important 
secreted factor from the motor neuron in the context of NMJ formation is the 
proteoglycan agrin. The importance of this protein is demonstrated by the fact that mutant 
mice that are missing agrin fail to cluster AChRs after innervation and die before birth 
(Gautam et al., 1996).  It is interesting to note that aneural muscle fibers are able to form 
AChR clusters before neuronal innervation, which indicates that neuronal agrin isn’t the 
only source of clustering (Yang et al., 2001). This may be explained by the fact that agrin 
is also synthesized by muscle fibers and schwann cells, albeit it is ~1,000x less effective 
than neuronal agrin at AChR clustering (Gesemann et al., 1995).  
 
MuSK 
Neuronal agrin has the ability to cluster AChRs by binding to the Muscle Specific 
Kinase receptor (MuSK) on the muscle membrane. The activation of MuSK by Agrin  
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leads to MuSK’s autophosphorylation, which affects many downstream signaling 
pathways that lead to the accumulation of proteins in the membrane of the muscle fiber 
(Darabid et al., 2014). In mutant mice missing MuSK receptors, AChRs fail to cluster in 
both aneural and neuronally innervated muscle fibers even in the presence of agrin 
(DeChiara et al., 1996). This suggests that MuSK plays an important role in both AChR 
prepatterning and in AChR clustering in response to neuronal agrin. MuSK also appears 
to be crucial for proper presynaptic differentiation, as MuSK mutant exhibit highly 
branched motor neuron terminals that cover a broader region of the muscle (Glass et al., 
1996). The potency of this complex’s ability to regulate synapse formation is 
demonstrated by the fact that ectopic expression of MuSK in agrin deficient mice rescues 
them from lethality (Kim & Burden, 2008).  
 
Lrp4 and Dok7 
Agrin exerts its effects of AChR clustering by binding to the MuSK co-receptor 
Lrp4 (Glass et al., 1996; Zhang et al., 2008). Mutant mice that lack this single-pass 
transmembrane protein show a similar phenotype to that of the Musk -/- mutant mice; 
AChRs fail to cluster in both aneural and neuronally innervated muscle fibers even in the 
presence of agrin (Weatherbee et al., 2006). The binding of agrin to Lrp4 is necessary for 
the clustering of AChRs by MuSK (Zhang et al., 2008). Another protein that is required  
for MuSK activation and further downstream activity is the adapter protein downstream-
of-tyrosine-kinase-7 (Dok7). Mutant mice missing Dok7 neither form AChR clusters or 
NMJs (K. Okada, 2006). It is still unclear how exactly Lrp4 regulates MuSK activity, but  
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there are several hypotheses; by directly binding agrin or by transducing intracellular 
signals through an adapter protein such as Dok7 (Wu et al., 2010). 
 
Agrin/Lrp4/MuSK Signalling Complex 
 How exactly MuSK activation leads to AChR clustering remained a mystery until 
recently. It has been shown that in response to agrin, Musk becomes rapidly internalized 
through receptor endocytosis by N-ethylmaleimide sensitive factor (NSF) (Zhu et al., 
2008).  But what exactly occurs once MuSK has been internalized? In order for AChRs to 
cluster themselves on the muscle membrane, there must be some sort of cytoskeletal 
reorganizer that allows them to properly associate with the membrane (Dai et al., 2000). 
It is thought that Abl1 kinase and geranylgeranyl transferase I (GGT) are some of the 
critical downstream mediators activated by MuSK that lead to the cytoskeletal 
reorganization that allows for AChR clustering (Finn et al., 2003; Luo et al., 2003). As a 
consequence, Rac and Rho GTPases are activated (Weston et al., 2003) One target of the 
activated Rho GTPase is the serine/threonine kinase Pak1. Pak1 associates to MuSK by 
binding to the signaling molecule Disheveled (Dvl) (Luo et al., 2002). Disruption of the 
interaction between MuSK and Dvl inhibits AChR clustering and inhibition of Pak1 
severely reduces AChR clustering (Luo et al., 2002). Pak1 may regulate the actin 
dynamics of AChR clustering either by phosphorylating the cytoskeletal remodeling 
protein cortactin (Webb et al., 2006), by suppressing myosin light chain kinase (MLCK) 
and reducing the association between myosin light chains and actin (Wu 2010), or by 
indirectly inhibiting the activity of the actin depolymerizing factor ADF/cofilin through  
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the activation of LIM kinase (Lee et al., 2009).  
 
Activity-Dependent Development of the NMJ 
 Acetlycholine (ACh) secreted from lower motor neurons binds to 
acetlycholine receptors (AChRs) on muscle fibers and causes an influx of calcium 
into the cytoplasm of the muscle fibers. Calcium influx activates protein kinase C 
(PKC), which goes on to phosphorylate the myogenic factors that participate in the 
transcriptional program that modulates AChR expression. It has been shown that 
genetic knock-out mutant mice lacking the neurotransmitter ACh have increased 
numbers of AChR clusters and the neuron hyper-innervates the muscle fiber 
(Brandon et al., 2003; An et al., PNAS 2010). Thus, neuronal activity acts as a 
negative regulator of lower motor neuron development that modulates neuronal 
morphology and differentiation of the NMJ.   
 
Elimination 
During nervous system development many neurons produce  
more synapses then will remain into adulthood. This plethora of synapses is often 
trimmed down through a process known as synaptic pruning, which is thought to  
contribute to proper circuit function. The mechanism that determines which 
synapses are eliminated and which ones survive is activity-dependent. Lower motor 
neurons undergo a comparable process of synaptic pruning.  Instead of overtly 
eliminating synapses, neurons initially innervate multiple synapses (poly-neuronal  
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innervation) and subsequently prune projections until each NMJ is innervated by a 
single motor neuron (mono-neuronal innervation).  During this process, as one 
synapse strengthens the others become weaker (Colman et al., 2017). There is also a 
temporal dynamic to this process, this typically occurs during the first two weeks of 
rodent development. It has been shown that blocking neuronal activity delays the 
process of synaptic pruning (Barry & Ribchester, 1995), while increasing neuronal 
activity accelerates the process (Duxson & Vrbová, 1985). Synaptic pruning is a 
competitive process. Studies show that inhibition of a single motor neuron during 
synaptic competition leads to a prolonged reduction in the number of innervated 
NMJ’s compared to neighboring neurons that remain active (Buffelli et al., 2003). 
 
Survival 
 During development of the nervous system approximately 50% percent of all 
neurons undergo programmed cell death (PCD) (Oppenheim, 1991). Many people 
have speculated as to why the nervous system develops such an overabundance of 
neurons, but one theory suggests PCD is important for control of ‘systems matching’ 
between neuronal populations and their targets (Oppenheim, 1991). The process of 
PCD appears to be activity-dependent as it has been shown that blocking NMJ 
activity leads to increased motor neuron survival (Pittman & Oppenheim, 1978). It 
appears that PCD in individual subsets of neurons is differentially regulated. 
Abolishing GABAergic and glycinergic synaptic inputs onto developing motor 
neurons increases limb-innervating motor neuron survival, but decreases  
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respiratory motor neuron survival (Banks, 2005). However, regardless of the 
subtype of neuron, it is obvious that activity plays an important role in the proper 
development of the nervous system via control of neuronal survival. 
 
Summary 
Lower motor neuron development relies upon numerous cues that activate distinct 
signaling pathways. These cues include the FGFs, BDNFs, WNTs, and numerous others 
(Stifani, 2014). It has also been shown that proper signaling both onto and from the lower 
motor neuron is necessary for survival (Ikonomidou, 1999). FGF signaling and activity 
have been shown to activate Erk/MAPK and act as crucial mediators of NMJ 
development (Wu et al., 2010; Tsang & Dawid, 2004; Thomas & Huganir, 2004)). Since 
Erk/MAPK is necessary for the proper transduction of many extracellular cues and has 
also been linked to activity-dependent gene regulation, we hypothesized that Erk/MAPK 
is necessary for lower motor neuron development. Previous research has shown that 
embryonic lower motor neuron development does not require Erk/MAPK. Here we tested 
whether Erk/MAPK is required for postnatal lower motor neuron development during 
important phases of activity-dependent differentiation.  
Deficits in muscle development and neuromuscular control have been identified 
in Rasopathy patients (Johnson et al., 2011, Reinker et al., 2011, Souza et al., 2009, 
Stevenson et al., 2005, Tidyman et al., 2011, van der Burgt et al., 2007, & Viskochil et 
al., 2013).  To decipher the underlying causes of muscular phenotypes found in 
Rasopathy patients we have also tested whether lower-motor-neuron specific changes in  
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Erk/MAPK are sufficient to drive abnormalities in motor behavior. An understanding of 
the role of Erk/MAPK in postnatal lower motor neuron development may provide insight 
into candidate cellular mechanisms linked to neuromuscular abnormalities found in 
Rasopathy patients. 
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CHAPTER II MATERIALS AND METHODS 
 
Cre-Lox Recombination  
 The Cre-lox system is a very powerful genetic tool that allows researchers to 
control gene expression in specific cells at specific times. Cre-lox recombination works 
by inserting the gene for the Cre enzyme behind a promoter that is expressed in select cell 
types. This confines Cre expression, and subsequent Cre-dependent modifications, to 
specific cell types. Once the Cre enzyme is produced in the cell of interest it will bind 
engineered LoxP sites flanking the nucleic acid sequence of interest. Depending upon the 
orientation and placement of the loxp sites, this can work to either decrease, increase, or 
alter the expression of a specific gene.  
 Our strategy was to create a mouse model that allowed us to delete Erk/MAPK in 
the lower motor neurons. To do this we utilized the ChAT:Cre mouse that induces 
recombination at around E12 (Rossi et al., 2011). This would allow us to confine Cre 
expression to cholinergic expressing neurons. Past attempts to recombines Erk/MAPK in 
the lower motor neurons using the Olig2:Cre mouse, induced recombination at E9.5 in 
both lower motor neurons and oligodendrocytes and led to neonatal lethality (Newbern et 
al., 2011). We bred the ChAT:cre mouse model to Erk1-\-, Erk2loxp/loxp mice so that we 
could remove both Erk1 and Erk2 (Samuels et al., 2008). Erk1 can be removed from the 
mouse without any adverse side effects, but Erk2 cannot (Saba-el-leil et al., 2015). This is 
why we utilized cre-recombinase to remove Erk2. We also bred in an Ai9 reporter that 
produces fluorescent proteins in cells that express Cre (Madisen et al., 2010).  
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Transcription of the Ai9 reporter will only occur once the LoxP-flanked STOP cassette is 
deleted through Cre-recombination. The ChAT:Cre+/- , Erk1-\-, Erk2loxp/loxp, Ai9 +/- mouse 
that we generated using this strategy lives until ~P21, which allowed us to analyze early 
stages of postnatal lower motor neuron development.  
 We also generated a gain-of-function mouse model to study the effects of 
upregulating Erk/MAPK activity in lower motor neurons. Since most Rasopathies are due 
to gain-of-function mutations this mouse model would allow us to ascertain if any of the 
muscular phenotypes found in the Rasopathy patients were due to Erk/MAPK mutations 
in the motor neurons (Rauen et al., 2013). To accomplish this we bred a ChAT:Cre mouse 
to mouse with a constitutively active MEK1 mutation (Krenz et al., 2008). This gave us 
the ChAT:Cre +/-, CaMEK+/- mouse. This mouse model was also bred with an Ai9 
reporter. 
 
Generation of Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- mice 
 The breeding strategy outlined below is the one utilized to generate Chat:cre, 
Erk1-\-Erk2loxp/loxp , Ai9+/- mice. Firstly, homozygous ChAT:cre (ChAT:cre+/+) mice were 
bred with mice null for Erk1 and with loxp sites around Erk2 (Erk1-\-, Erk2loxp/loxp). The 
progeny of this cross led to the generation of ChAT:Cre+/- , Erk1+\-, Erk2wt/loxp mice. The 
ChAT:Cre+/- , Erk1+\- , Erk2wt/loxp mice were then bred with Erk1-\-, Erk2loxp/loxp to generate 
ChAT:Cre+/- , Erk1-\-, Erk2wt/loxp mice. Next, the ChAT:Cre+/- , Erk1-\-, Erk2wt/loxp mouse 
was crossed with the an Erk1-\-, Erk2oxp/loxp, Ai9 +/+ mouse to generate the ChAT:Cre+/- , 
Erk1-\-, Erk2wt/loxp, Ai9 +/- mouse (Control) and the ChAT:Cre+/- , Erk1-\-, Erk2loxp/loxp, Ai9 
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+/- mouse (Mutant). These two mice served as our control and mutant for the LOF portion 
of our study. 
 
Generation of ChAT:Cre +/-, CaMEK+/-, Ai9+/-  mice 
 The breeding strategy outlined below is the one utilized to generate Chat:cre+/-, 
CaMEK+/-, Ai9+/- mice. Firstly, homozygous CaMEK (CaMEK+/+) were bred with Ai9+/+ 
mice. The progeny of this cross led to CaMEK+/-, Ai9+/- mice. The CaMEK+/-, Ai9+/- mice 
were breed with CaMEK, Ai9+/+ mice to generate CaMEK+/+, Ai9+/+ mice. The 
CaMEK+/+, Ai9+/+ mice were then breed with ChAT:Cre+/+ mice. This generated 
ChAT:Cre+/- CaMEK+/-, Ai9+/- mice (mutant) and ChAT:Cre+/-, Ai9+/- mice (control). 
These two mice served as our control and mutant for the GOF portion of our study. 
 
Genotyping 
 Toe samples were taken using sharp scissors from juvenile pups (~P6-P10) to 
serve as tissue for genotyping material. The toes were individually placed into eppendorf 
tubes, lysis buffer was added to extract the DNA from the tissue, and the solution was 
heated to 50C for 30 minutes. Once the DNA was extracted, neutralizing buffer was 
added to the solution. The DNA samples were added to a mixture of Taq Polymerase, 
clean H20, and primers for actin, Erk2 loxP sites, CaMEK, and Ai9. The PCR program 
was set to denature the DNA at 95°C for 20 seconds, anneal primers at 60°C for 30 
seconds, and extend at 72°C for 30 seconds. This cycle was repeated 32 times. The 
sample was then cooled to 4°C. Once PCR amplification of the DNA was completed it  
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was placed into the electrophoresis gel. The gel was created by mixing 100ml TBE with 
1.8g agarose, heating it in the microwave for 90 seconds, pouring the mixture into a mold 
with EtBr, and allowing it to cool. Once the gel had solidified the amplified DNA was 
placed into individual wells and let run in the electrophoresis machine at 145V for 30min. 
The genotyping was then scanned and read to determine the genotype of our mice.  
 
Tissue Collection 
Perfusion and Tissue Collection 
Mice were anesthetized through IP injection of 200-400mg/kg tribromoethanol 
(Avertin). Once the mice were completely unconscious each mouse was pinned to a 
dissection tray. An incision was made below the sternum and, once exposed, the 
diaphragm was cut away. The rib cage was lifted and two parallel cuts were made thus 
exposing the heart. Using hemostats, the ribcage was lifted away to fully expose the 
heart. To perfuse the heart a peristaltic pump was used. The perfusion needle was inserted 
into the left ventricle of the heart and a small incision was made in the right atrium. The 
pump was activated and set to perfuse 5-10mL of 1X PBS into the circulatory system of 
the mouse. Once 1-2 minutes passed or once the liquid expelling from the right became 
clear, 15-30mL of 4% PFA/PBS was perfused into the mouse. The following samples 
were removed from the mice: Brain, cervical enlargement of the spinal cord, lumbar 
enlargement of the spinal cord, soleus, gastrocnemius, and diaphragm. 
 
Cryopreservation 
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 The next step was to freeze down the samples in OCT (Optimal cutting 
temperature compound) for either long-term storage or cryostat usage. To ensure that the 
samples didn’t form ice crystals while being frozen, the samples were immersed in a 
sucrose solution. The sucrose solution penetrates the tissue and acts as a cryoprotectant. 
To begin the mouse brain was placed into a solution of 15% sucrose over the first night 
and then placed in a solution of 30% sucrose over the second night. A similar protocol 
was used for the muscles and spinal cord segments, except the first night is skipped and 
samples are only immersed in 30% sucrose for one night.  
 Once the samples were properly saturated with sucrose the freezing could begin. 
In a rubber ice bucket bath of 70% ethanol and dry ice was made. While this was cooling 
small square molds (2x2x2in) were made using aluminum foil. The molds were filled 
with OCT and each of the samples was individually suspended in the OCT molds. The 
OCT molds were slowly lowered into the ethanol/dry ice bath and allowed to sit until 
completely frozen. Once frozen the samples were placed into long-term storage or 
immediately sectioned using the cryostat. 
 
Cryosectioning  
 The OCT blocks containing the samples were placed into a cryostat for 30 
minutes to allow the blocks to equilibrate to the temperature. The temperature varied 
depending on the tissue type; muscle was sectioned at -16 °C and the spinal cord  
segments were sectioned at -18 °C. Once the OCT block had time to equilibrate to the 
temperature of the cryostat it was placed secured to a sample stud using OCT and  
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attached to the chuck. The cryostat section thickness was then adjusted to 40μm for spinal 
cord segments and 80μm for muscles. As each section came off the plate it was placed 
onto a Superfrost Plus microscope slide with a fine-bristled brush.   
 
Immunohistochemistry 
The Superfrost Plus microscope slides containing the samples were attached to 
the slides by incubation on a slide warmer at 50°C for 10 minutes. The slides were then 
removed and circled with a PAP pen to create a reagent confinement zone. The slides 
were rinsed twice in a solution of PBS/0.05% Triton X-100 (PBST) for 10 minutes. The 
slides were then rinsed with PBS. The slides were then placed into a humidified slide 
chamber with 1ml of blocking solution (5%NDS/PBST) added to the slides and allowed 
to incubate for 30 minutes at room temperature. Once completed, the blocking solution 
was poured off the slides and primary antibodies diluted in blocking solution were added 
to the slides. The following primary antibodies were used: Sigma Aldrich DAPI (1:1000), 
Life Technologies a-Bungarotoxin Alexa Fluor 488 Conjugate (1:1000), Rockland Anti-
RFP Chicken Antibody (1:1000), Rockland Anti-RFP Rabbit Antibody (1:1000), SV2 
(1:1000), BioLegend Purified anit-Tubulin B3 (TUBB3, Clone: TUJ1)(1:1000), Millpore 
NeuN (1:1000), Millpore Anti-Choline Acetyltransferase (1:1000), Abcam Rb mAb to 
Erk2 [E460] (1:1000), and Abcam Rb Ab to Mek1 [E342]. The slides were placed into a 
humidified slide chamber and allowed to incubate overnight at 4°C. After the overnight  
incubation, the slides were rinsed three times in a solution of PBST for 60 minutes. The 
slides were then placed back into the humidified slide chamber with secondary antibodies  
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diluted in blocking solution added to the slides. The following secondary antibodies were 
used: Alexa Fluor 488 Donkey anti-mouse (1:1000), Alexa Fluor 488 Donkey anti-rabbit 
(1:1000), Alexa Fluor 488 Donkey anti-goat (1:1000), Alexa Fluor 555 Donkey anti-
mouse (1:1000), Alexa Fluor 555 Donkey anti-mouse (1:1000), Alexa Fluor 567 Donkey 
anti-mouse (1:1000), and Alexa Fluor 647 Donkey anti-mouse (1:1000). The slides were 
allowed to incubate overnight at 4°C. After the overnight incubation, the slides were 
rinsed three times in a solution of PBS for 30 minutes. Once completed, excess buffer 
was removed and slides were coverslipped with Fluoromount. 
 
Histochemical Analysis 
Motor Neuron Counts 
To assess motor neuron survival, sections from the L4-L5 region of the spinal 
cord were sampled. Ai9 positive lower motor neurons from the lateral motor column 
were counted from every fourth 40μm section throughout the entire L4-L5 region of the 
spinal cord. The observer was blinded to experimental group. The average number of 
motor neurons were calculated for the entire region and compared between mutant and 
control.    
 
Plaque-to-Pretzel 
 To assess whether the NMJs of the mice had properly transitioned from a plaque 
shaped morphology to a pretzel shaped morphology we performed a qualitative 
assessment. The observer was blinded to experimental group. Ten BTX-labeled NMJs  
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from every 3rd 80μm section of the gastrocnemius muscle were randomly chosen for  
morphology assessment until ~100 were measured. The morphologies of the NMJs were 
characterized as either being plaque, transitioning, or pretzel. The percentage of plaque 
shaped, transitioning, and pretzel shaped NMJs of three pairs of control/mutant mice 
were then compared.   
 
NMJ Area 
 To assess for the total area of the average NMJ we performed a quantitative 
measurement.  5 BTX-labeled NMJs from every 3rd 80μm section of the gastrocnemius 
muscle were randomly chosen until 50 were measured. The observer was blinded to 
experimental group.  Area measurements were taken from three control/mutant pairs of 
mice using the LASX Leica software. 
 
Poly-to-Mono Counts 
 To assess the if NMJs had undergone the process of synaptic pruning we analyzed 
150 random Ai9 expressing NMJs from the gastrocnemius muscle and determined if they 
were poly-neuronally innervated or mono-neuronally innervated. The observer was 
blinded to experimental group.  The number of poly-neuronal vs. mono-neuronal NMJs 
were then compared across three age-matched pairs.  
 
Behavioral Testing 
Rotarod 
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Rotarod was used to assay the ability of the mice to coordinate their limbs and ascertain if 
any motor defects were present. The rotating platform was programmed to  
increase from 0 to 40 RPMs over the period of 5 minutes. This was repeated for 3 trials a 
day with 15 minutes in between each trial. This was repeated for 5 days.  
   
Open Field 
 To perform the open field assay we acquired a 40cm x 40cm x 40cm plastic box 
and positioned a camera and light above it. The light was positioned to illuminate the box 
while the camera acquired video. The behavioral assay consisted of placing the mouse 
into the box while it’s pattern of activity was recorded for 10 minutes. We analyzed the 
video with the Open Field plug-in for ImageJ.    
 
Rope Test 
A vertical rope-climbing test was used to assay both motor coordination and grip 
strength. The assay involved placing a mouse at the bottom of a suspended nylon rope 
(50cm length, 1-1.5cm thickness) with regularly placed knots. The rope was suspended 
45cm above a large box filled with padding (foam blocks) to protect the mice from injury 
if they should fall. The box of foam was covered with thin plastic sheeting so that any 
waste dropping from the climbing mouse didn’t contaminate the foam. The time it takes 
the mouse to ascend the rope was measured. Trials were stopped after 2 minutes. This 
was done on one day with three trials per mouse. 
 
Weighted Object Test 
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For this assay, the ability of the mouse to lift a metal weight was tested. A metal 
scouring pad was attached to a metal weight (steel chain links ranging from 5-85g) and 
placed in front of the mouse. Once the mouse grabbed the scouring pad, it was slowly 
raised by the base of its’ tail until the entire weight was suspended in the air. If the mouse 
dropped the weight, the trial was repeated until three attempts were made. If the mouse 
was able to hold the weight in the air for 3 seconds, it was gently placed back onto the 
table and tested at the next increment in weight. This was repeated until the mouse was 
unable to hold the weight in the air for three seconds in at least one of three attempts. The 
test included one day of habituation and one testing day. 
 
Morris Water Maze 
 To test the memory and swimming ability of the mice we utilized the Morris 
Water Maze. A metal pool was filled with water until the hidden platform lay just below 
the surface of the water. To ensure that the mouse wouldn’t be able to see the platform, 
non-toxic white paint was added to the water until the platform wasn’t visible. Symbols 
were added to the walls of the room to provide spatial cues for the mouse to remember 
the location of the platform. To perform the assay, mice were placed into a random 
quadrant of the pooled and allowed to swim for 60 seconds. If the mouse finds the 
platform it is left to rest for 15 seconds before being dried off and placed onto a heating 
pad. If the mouse couldn’t find the platform in 60 seconds it was led to the platform and 
left to rest for 15 seconds before being dried off and placed onto a heating pad. This was 
repeated for 4 trials per day with 15 minutes of rest in between each trial over a period of  
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5 days. On the 5th day mice underwent a 5th trial consisting of a probe test. This involved 
taking the platform away from the pool to observe the swimming strategy employed by 
the mouse.  Video was then scored using the Water Maze ImageJ plugin. 
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CHAPTER III - LOSS OF FUNCTION ERK/MAPK RESULTS 
 
 To assess the requirement of Erk/MAPK signaling in postnatal lower motor 
neuron development we developed a mouse model where Erk1/2 was deleted in lower 
motor neurons in a Chat:cre, Erk1-\-Erk2loxp/loxp model. This model allowed us to 
successfully confine Erk/MAPK deletion to cholinergic expressing neurons. Even though 
the mutant mice died by three weeks of age, we were able to assess the postnatal 
development of lower motor neurons in the absence of Erk/MAPK during critical stages 
of early postnatal development. Previous attempts to assess Erk/MAPK function in the 
spinal cord used a similar strategy with an Olig2:Cre mouse (Newbern et al., 2011). This 
mouse model induced recombination at E9.5 in the spinal cord progenitor domain that 
produces motor neurons and oligondendrocytes, however, mutants died at birth. Thus, the 
Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- mouse provides a unique opportunity to cell-
autonomously assess the postnatal development of lower motor neurons in the absence of 
Erk/MAPK.  
 
Mouse Model Confirmation: Choline Acetyltransferase Expression 
 To assess whether we successfully induced the mutation in the lower motor 
neurons of the Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- mice, we performed 
immunohistochemical analysis of L4 lumbar spinal cord segments. We performed this 
analysis for three mutants and three controls. We found that all Ai9 expressing cells 
colocalized with ChAT expression, which confirmed that our reporter was in the lower 
motor neurons (Figure 8).  
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Figure 8: LOF P18 ChAT Expression 
 
Mouse Model Confirmation: Erk2 Expression 
 To assess whether our mutation worked in the Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- 
mice we performed an immunohistochemical analysis of Erk2. We performed this 
analysis for three mutants and three controls. The mutants exhibited a complete loss of 
Erk2 expression in Ai9-expressing lower motor neurons relative to controls (Figure 9). 
 
 35
 
Figure 9: P18 LOF ERK2 Expression 
 
Motor Neuron Counts 
In order to assay motor neuron survival in the Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- 
mice we counted the average number of Ai9 expressing motor neurons from every fourth 
40μm slice of the L4-L5 region of the lateral motor column within the spinal cord of the 
mice and compared the number to age matched P18 controls (Figure 10). We performed 
this analysis for three mutants and three controls. We found an average number of 
36.69±8.95 motor neurons per section in the mutant compared to an average number of 
38.56±9.97 of motor neurons per section in the control (Figure 11). The result of a two-
tailed t-test revealed a non-significant value of 0.41. Thus, Erk/MAPK does not appear to 
be necessary for lower motor neuron survival. 
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Figure 10: LOF P18 L4 Region of the Spinal Cord 
 
 
Figure 11: LOF P18 Motor Neuron Counts 
 
NMJ Area 
In order to assay the total area that AChRs took up in the NMJs of the Chat:cre, 
Erk1-\-Erk2loxp/loxp , Ai9+/-  we measured the area of 50 BTX labeled NMJs and compared 
the results to age matched P18 controls. We performed this analysis for four mutants and 
four controls. We found that the average area of NMJs in the mutant was  
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266.84μm2±16.56μm2 compared to the average area of 258.47μm2±11μm2 in the control 
(Figure 12). The result of a two-tailed t-test revealed a non-significant value of 0.43. 
The analysis was also done for Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- mice at P10 
and their age match controls. We performed this analysis for three mutants and three 
controls. We found that the average area of NMJs in the mutant was 
139.13μm2±13.52μm2 compared to the average area of 167.04μm2±26.41μm2 in the 
control (Figure 12). The result of a two-tailed t-test revealed a non-significant value of 
0.18. The results of this assay provided strong evidence that the area of the postsynaptic 
portion of the NMJ is independent of Erk/MAPK. 
 
Figure 12: LOF P10 & P18 NMJ Area 
 
Presynaptic NMJ Area 
In order to analyze the total area that the axon took up on the NMJs of the 
Chat:cre, Erk1-\-Erk2loxp/loxp, Ai9+/-  we measured the area of 20 Ai9 expressing NMJ 
synapses and compared the results to age matched P10 controls. We performed this 
analysis for three mutants and three controls. We found that the average area of Ai9 
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expressing NMJ synapses in the mutant was 58.04μm2±19.31μm2 compared to the 
average area of 73.28μm2±5.32μm2 in the control (Figure 13). The result of a two-tailed 
t-test revealed a non-significant value of 0.26. The results of this assay provided strong 
evidence that the area of the presynaptic portion of the NMJ is independent of 
Erk/MAPK. 
 
Figure 13: LOF P10 Area of the Presynaptic Portion of the NMJ 
 
Presynaptic NMJ Binary Masking  
 We performed a qualitative analysis of the presynaptic membrane of the Chat:cre, 
Erk1-\-Erk2loxp/loxp , Ai9+/- mice by converting images of the NMJs into monochrome 
images. These images were compared to those of a P10 age matched control. We 
performed this analysis for three mutants and three controls. We found no noticeable 
difference between the appearance between the mutants and controls (Figure 14).  In 
summary, we conclude that ERK/MAPK signaling is not necessary for the development 
of the size of pre- or post-synaptic structure during NMJ differentiation. 
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Figure 14: Structural Analysis of the Presynaptic Portion of the LOF NMJ 
 
Plaque to Pretzel 
 To determine if the NMJs of the Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- mice had 
properly matured we assessed the morphology of 315 random BTX labeled NMJs from 
the gastrocnemius muscle across three mutants and 310 random BTX labeled NMJs 
across three age-matched P18 controls (Figure 15). We found an average of 40±10.44 of 
the NMJs in the mutant were still in the plaque phase of maturation compared to 
18.67±3.51 in the control, 62.67±11.85 were transitioning in the mutant compared to 
50.33±10.69 in the control, and only 2.33±2.52 matured into a pretzel-shaped 
morphology in the mutant compared to 37.67±12.02 in the control (Figure 16). The 
results of two-tail t-tests for the three analyses revealed a significant difference between 
the percentage of NMJs still in the plaque phase (p=0.03) and the percentage of NMJs 
that had matured to the pretzel phase (p=0.01). The t-test for the percentage of NMJs that 
were transitioning yielded non-significance (p=0.25). The results of this assay indicate 
that the proper morphological change from plaque-to-pretzel at the NMJ is Erk/MAPK 
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dependent.  
  
 
Figure 15: LOF P18 Plaque to Pretzel Qualitative Analysis 
 
Figure 16: LOF P18 NMJ Plaque to Pretzel Quantitative Analysis 
 
The analysis was also done for Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- mice at P10 
and their age match controls. We performed this analysis for three mutants and three 
controls. We found that 71.08%±1.77 of the NMJs in the mutant were still in the plaque  
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phase of maturation compared to 57.25%±5.86% in the control and 28.92%±1.77% were 
transitioning in the mutant compared to 42.75%±5.86% in the control (Figure 17). The 
results of two-tail t-tests revealed a significant difference between the percentage of 
NMJs still in the plaque phase (p=0.02) and the percentage of NMJs that had entered the 
transitional phase (p=0.02). The results of this assay indicate that even at earlier stage of 
postnatal development that the proper morphological change from plaque-to-pretzel at the 
NMJ is Erk/MAPK dependent. 
  
 
Figure 17: LOF P10 NMJ Plaque to Pretzel Quantitative Analysis 
 
Poly-to-Mono Counts 
To assess whether the NMJs of the Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- underwent 
the process of poly-neuronal innervation to mono-neuronal innervation we counted the 
number of synapsing axon found at 150 random Ai9 expressing NMJs from the 
gastrocnemius muscle and compared them to age matched P18 controls. We performed 
this analysis for three mutants and three controls.  The average number of NMJs in the 
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mutant that were poly-neuronally innervated was 4.39%±4.39% compared to 
3.26%±2.82% in the control (Figure 18, 20). The average number of NMJs in the mutant 
that were mono-neuronally innervated was 95.61%±3.41% compared to 96.74%±2.82% 
in the control (Figure 19, 20). The result of two-tailed t-tests for both of the analyses 
revealed non-significant values of 0.68. It can be concluded that the transition from poly-
to-mono neuronal innervation is Erk/MAPK independent.  
 
Figure 18: LOF P18 Control Poly-to-Mono Qualitative Analysis 
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Figure 19: LOF P18 Mutant Poly-to-Mono Qualitative Analysis 
 
 
Figure 20: LOF P18 Poly-to-Mono Quantitative Analysis 
In order to ascertain the rate at which NMJs of the Chat:cre, Erk1-\-Erk2loxp/loxp , 
Ai9+/- mice undergo synaptic pruning we counted the number of synapsing axons found 
at 150 random Ai9 expressing NMJs from the gastrocnemius muscle and compared them 
to age matched P10 controls. We performed this analysis for three mutants and three  
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controls.  The average number of NMJs in the mutant that were poly-neuronally 
innervated was 13.17%±7.86% compared to 7.04%±3.7% in the control (Figure 21). The 
average number of NMJs in the mutant that were mono-neuronally innervated was 
86.83%±7.86% compared to 92.96%±3.7% in the control.  The result of two-tailed t-tests 
for both of the analyses revealed non-significant values of 0.29. The results of this assay 
indicate that the rate at which the NMJs experience synaptic pruning is similar between 
the mutants and controls.  
 
Figure 21: LOF P10 Poly-to-Mono Quantitative Analysis 
 
Synaptic Vesicle Clustering 
 To uncover whether the NMJs of Chat:cre, Erk1-\-Erk2loxp/loxp , Ai9+/- mice 
exhibited normal clustering of vesicles in the presynaptic portion of the NMJ we 
performed immunohistochemical analysis with the SV2 antibody. We performed this 
analysis for three mutants and three controls. We found that both mutants and controls 
exhibited normal clustering of vesicles confined to the most distal part of the synapses 
(Figure 22). 
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Figure 22: LOF P18 Synaptic Clustering 
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CHAPTER IV GAIN OF FUNCTION ERK/MAPK RESULTS 
 
Mouse Model Confirmation: Choline Acetyltransferase Expression 
 To assess whether we successfully induced the mutation in the lower motor 
neurons of the ChAT:Cre +/-, CaMEK+/-, Ai9+/-  mice, we performed 
immunohistochemical analysis of L4 lumbar spinal cord segments. We performed this 
analysis for three mutants and three controls. We found that all Ai9 expressing cells 
colocalized with ChAT expression, which confirmed that our reporter was in the lower 
motor neurons (Figure 23).  
 
Figure 23: GOF P60 ChAT Expression 
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Mouse Model Confirmation: MEK Expression 
To assess whether the mutation worked in the ChAT:Cre +/-, CaMEK+/-, Ai9+/-  
mouse model we performed an immunohistochemical analysis of MEK1. We performed 
this analysis for three mutants and three controls. The mutants exhibited higher MEK1 
expression in lower motor neurons than the controls (Figure 24). 
 
 
Figure 24: GOF P60 MEK Expression 
 
Motor Neuron Counts 
To assess motor neuron survival in the ChAT:Cre +/-, CaMEK+/-, Ai9+/-  mice we 
counted the average number of Ai9 expressing motor neurons from every fourth 40μm 
slice of the L4-L5 region of the lateral motor column within the spinal cord of the mice 
and compared the number to age matched P10 controls (Figure 25). We performed this  
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analysis for three mutants and three controls. We found an average number of 34.52±1.37 
in the mutant compared to an average number of 34.81±3.64 in the control (Figure 26). 
The result of a two-tailed t-test revealed a non-significant value of 0.87. Thus we can 
conclude that upregulation of Erk/MAPK has no noticeable effect on motor neuron count.  
 
 
Figure 25: GOF P60 L4 Region of the Spinal Cord 
 
Figure 26: GOF P60 Motor Neuron Counts 
 
NMJ Area 
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To assess the total area that AChRs took up in the NMJs of the Chat:cre, 
CaMEK+/-, Ai9+/-  we measured the area of 50 BTX labeled NMJs and compared 
the results to age matched P60 controls. We performed this analysis for three 
mutants and three controls. We found that the average area of NMJs in the mutant 
was 420.48μm2±28.78μm2 compared to the average area of 414.25μm2±2.8μm2 in 
the control (Figure 27). The result of a two-tailed t-test revealed a non-significant 
value of 0.73. The results of this assay indicate that the upregulation of 
Erk/MAPK has no noticeable effect on NMJ area at P60. 
 
Figure 27: GOF P60 Quantitative Analysis of NMJ Area 
 
The analysis was also done for Chat:cre, CaMEK+/-, Ai9+/- mice at P10 and their 
age match controls. We performed this analysis for three mutants and three controls. We 
found that the average area of NMJs in the mutant was 171.59μm2±22.52μm2 compared 
to the average area of 162.22μm2±20.85μm2 in the control (Figure 28). The result of a 
two-tailed t-test revealed a non-significant value of 0.62. The results of this assay indicate 
that the upregulation of Erk/MAPK has no noticeable effect on NMJ area at P10. 
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Figure 28: GOF P10 Quantitative Analysis of NMJ Area 
 
Plaque-to-Pretzel 
To determine if the NMJs of the Chat:cre, CaMEK+/-, Ai9+/- mice were properly 
maturing we assessed the morphology of 100 random BTX labeled NMJs from the 
gastrocnemius muscle and compared them to age matched P10 controls. We performed 
this analysis for three mutants and three controls.  We found that 65.12%±12.8% of the 
NMJs in the mutant were still in the plaque phase of maturation compared to 
60.96%±9.06 in the control and 34.88%±12.18% were transitioning in the mutant 
compared to 39.04% ±9.06% in the control (Figure 29). The results of two-tail t-tests 
yielded a non-significant difference between the percentage of NMJs still in the plaque 
phase (p=0.66) and the percentage of NMJs that had entered the transitional phase 
(p=0.66). Thus we can conclude that an upregulation of Erk/MAPK doesn’t affect the 
proper morphological maturation of the NMJ from plaque-to-pretzel.  
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Figure 29: GOF P10 Plaque to Pretzel Quantitative Analysis 
 
Poly-to-Mono Counts 
To assess the rate at which NMJs of the Chat:cre, CaMEK+/-, Ai9+/- mice undergo 
synaptic pruning we counted the number of synapsing axon found at 150 random Ai9 
expressing NMJs from the gastrocnemius muscle and compared them to age matched P10 
controls. We performed this analysis for three mutants and three controls.  The average 
number of NMJs in the mutant that were poly-neuronally innervated was 11.78%±8.77% 
compared to 8.9%±6.7% in the control (Figure 30). The average number of NMJs in the 
mutant that were mono-neuronally innervated was 88.22%±8.77% compared to 
91.1%±6.7% in the control. The result of two-tailed t-tests for both of the analyses 
revealed non-significant values of 0.29. Thus we can conclude that the temporal 
dynamics of synaptic pruning are left intact in the presence of an upregulation of 
Erk/MAPK activity.  
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Figure 30: GOF P10 Poly-to-Mono Quantitative Analysis 
 
Rotarod 
 To ascertain whether the Chat:cre, CaMEK+/-, Ai9+/- mouse was able to coordinate 
its limbs and successfully perform a rigorous physical task we utilized the rotarod. For 
this behavioral assay we used 14 mutants and 10 age matched P60 controls (Figure 31). 
Though both groups showed statistically significant increases in the time they remained 
on the rotarod over the five-day period, there was no statistically significant difference 
between the two groups on day one (p= 0.202) or day five (p= 0.745) (Figure 32). The 
results of this behavioral assay show that an upregulation of Erk/MAPK doesn’t affect 
the ability for the mice to balance and coordinate itself to perform this task.  
 
 Control 
Average 
Latency 
Control 
Standard 
Deviation 
Mutant Average 
Latency 
Mutant 
Standard 
Deviation 
Day 1 78.15 seconds 27.48 seconds 65.67 seconds 19.14 seconds 
Day 2 86.32 seconds 14.69 seconds 85.3 seconds 20.42 seconds 
Day 3 114.85 seconds 34.16 seconds 96.02 seconds 17.30 seconds 
Day 4 112.09 seconds 24.84 seconds 103.14 seconds 28.86 seconds 
Day 5 130.18 seconds 26.44 seconds 126.95 seconds 21.63 seconds 
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Figure 31: GOF Rotarod Data 
 
 
Figure 32: GOF Rotarod 
 
Open Field 
 To ascertain whether the Chat:cre, CaMEK+/-, Ai9+/- mouse had any detectable 
gross motor defects we utilized the open field behavioral paradigm. For this behavioral 
assay we used 12 mutants and 13 age matched controls ranging from ages P60-P180. 
Over a period of five minutes there was no statistically significant difference between 
total distance travelled (p= 0.953) or rate of travel (p= 0.746) between the two groups 
(Figure 33). The results of this behavioral assay show that an upregulation of Erk/MAPK 
doesn’t affect gross motor behavior. 
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Figure 33: GOF Open Field 
 
Weighted Object Test 
To ascertain whether the Chat:cre, CaMEK+/-, Ai9+/- mouse had problems with 
forelimb strength we utilized a weighted object test. For this behavioral assay we used 12 
mutants and 9 age matched controls ranging from ages P80-P240. There was no 
statistically significant difference between the amounts of weight the two groups could 
hold (p= 0.532) (Figure 34). Thus it appears that an upregulation of Erk/MAPK doesn’t 
affect the mouse’s strength in this context.  
 
 
Figure 34: GOF Forelimb Test 
 55
 
Morris Water Maze 
To ascertain whether the Chat:cre, CaMEK+/-, Ai9+/- mouse had any detectable 
spatial memory deficits we utilized the Morris Water Maze. For this behavioral assay we 
used 12 mutants and 13 age matched controls ranging from ages P70-P230. Over a period 
of five days both groups took significantly less time to reach the reach the platform, 
however there was no statistically significant difference between the two groups 
performances on day one (p= 0.48) or day five (p= 0.65) (Figure 35). The results of this 
behavioral assay indicate that swim performance between the mutants and controls is 
intact and so is spatial memory acquisition and retrieval.  
 
 
Figure 35: GOF Morris Water Maze 
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To ascertain whether the Chat:cre, CaMEK+/-, Ai9+/- mouse had problems with 
forelimb strength we utilized a rope climbing assay. For this behavioral assay we used 9 
mutants and 6 age matched controls ranging from ages P80-P240.  The animals were 
habituated for one day. There was no statistically significant difference between the two 
groups performances on training day (p= 0.146) or testing day (p= 0.105) (Test day, 
Figure 36). Thus it appears that an upregulation of Erk/MAPK doesn’t affect the mouse’s 
strength in this context. 
 
 
Figure 36: GOF Rope Climbing  
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CHAPTER V DISCUSSION 
 
Previous work demonstrated that embryonic lower motor neuron survival, 
outgrowth, and NMJ formation is Erk1/2 independent (Newbern et al., 2011). We have 
assessed the functions of Erk1/2 in lower motor neurons during postnatal development. 
We have also assessed the effects of upregulating ERK/MAPK activity. The analysis has 
led to several conclusions. First, the loss of Erk/MAPK leads to a delay in NMJ 
morphological maturation, but left intact many other aspects of the postnatal development 
of lower motor neurons. Second, we found little evidence to suggest that the upregulation 
of ERK/MAPK activity has any effect on lower motor development.  
 
Chat:Cre, Erk1/2, Loss-Of-Function Mouse Model 
Newbern et al. 2011 investigated the role of Erk1/2 in motor neuron and 
oligodendrocyte development by utilizing Olig2:Cre directed recombination. The 
Olig2:Cre mouse induced recombination at E9.5 in ventral spinal cord progenitors that 
generate lower motor neurons and oligodendrocytes. Deficits in oligodendrocyte number 
were detected, however, since this mouse model died at birth, we were unable to study 
motor neuron development into the postnatal period. With the development of a mouse 
model that induces Cre recombination in lower motor neurons and lives past birth our 
research was aimed at addressing the role that Erk1/2 plays in the postnatal development 
of lower motor neurons.  
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Cell Survival in the Chat:cre, Erk1/2 LOF model 
 Motor neuron survival depends upon many different neurotrophins (Stifani, 
2014). What these neurotrophins do and what signaling pathways they activate are well 
understood, but the precise functions of downstream signaling pathways are poorly 
defined.  Previous research has shown that Erk1/2 signaling regulates cell survival in 
specific neuronal subtypes by promoting anti-apoptotic or pro-apoptotic transcription 
factors (Lu & Xu, 2006). Since motor neurons survive in the Chat:Cre LOF model we 
can conclude that lower motor neuron survival is Erk1/2 independent and is likely 
dependent upon other signaling pathways. One signaling pathway that could perhaps be 
more relevant for lower motor neuron survival is the PI3-kinase/Akt/mTOR pathway 
(Crowder & Freeman, 1998; Datta et al., 1997; Newbern et al., 2005; Philpott et al., 
1997; Viewpoints, 1997). Previous research has shown that upregulated levels of mTOR 
activity protects against ALS induced motor neuron death (Saxena et al., 2013). Other 
research has shown cross talk between Erk1/2 and mTOR activity (Dai et al., 2014). 
Thus, it is possible that eliminating Erk1/2 signaling has no affect on lower motor neuron 
survival due to compensatory changes in mTOR or PI3-Kinase activity.  
 
Activity-Dependent Mechanisms and Erk1/2 Signaling 
Previous research has shown that glutamate receptor activation leads to high 
levels of phosphorylated Erk in several neuronal subtypes (Wang et al., 2007). 
Erk/MAPK is required for the insertion of new AMPA receptors into the dendritic spines 
of forebrain excitatory neurons during LTP and repeated depolarization of hippocampal  
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neurons induced the formation of new spines in an Erk/MAPK dependent manner 
(Lisman et al., 2001; Wu et al., 2001). Since activation of the Erk/MAPK pathway has 
been shown to be an integral part of activity dependent synaptic plasticity in many parts 
of the nervous system, we hypothesized Erk/MAPK is necessary for the activity-
dependent morphological maturation of the lower motor neuron and the NMJ (Thomas & 
Huganir, 2004).  
An examination of the electrophysiological properties of the lower motor neurons 
in the absence of Erk/MAPK would provide an important direct indicator of neuronal 
activity in mutant mice. However, the early lethality of LOF mice in the third postnatal 
week due to as yet unknown causes limited our ability to analyze this issue in detail. 
Overall, the mice exhibit growth delay and exhibit tremors. We cannot exclude that 
deficits in other cholinergic neurons, such as the sympathetic and parasympathetic 
neurons, could contribute to lethality. Nonetheless, our analysis of lower motor neurons 
demonstrates that Erk/MAPK is required for select developmental processes linked to 
activity, specifically, the morphological maturation of the NMJ into a ‘pretzel’-like 
morphology. In contrast, other activity-dependent events, such as neuronal survival and 
the transition from mono-neuronal to poly-neuronal innervation were unaffected.  Overall 
these data suggest the Erk/MAPK signaling mediates specific aspects of activity-
dependent lower motor neuron development. Our work hints at the presence of distinct 
activity-dependent signaling mechanisms differentially linked to certain cellular 
processes.  Further work will be necessary to identify the precise identity of these crucial 
molecular mediators. 
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Neuromuscular Junction Maturation in the Chat:Cre, Erk1/2 LOF Model 
  Previous research has shown that lower motor neuron synaptogenesis is Erk1/2 
independent (Newbern et al., 2011). Subsequent maturation of the lower motor neuron 
NMJs in an Erk1/2 LOF model hasn’t been studied. Our analysis led us to the conclusion 
that the proper morphological maturation of the NMJ is Erk1/2 dependent. NMJs in the 
LOF model fail to properly transition from plaque-to-pretzel morphology in the absence 
of Erk1/2. It is important to note that the ability of the postsynaptic membrane to mature 
occurs independent of any detectable defects in presynaptic morphology. Since our LOF 
model affected the lower motor neurons, not the muscle or surrounding Schwann cells, 
the failure for NMJs to properly mature could be linked to an inability to transduce the 
effects of growth cues from surrounding cells.  
 
Signaling on The Presynaptic Membrane 
FGF signaling has been shown to be crucial for the proper development of NMJs 
(Wu et al., 2010). It has also been shown that FGF signaling can recruit ERK/MAPK 
activity (Tsang & Dawid, 2004). These lines of reasoning lead us to hypothesize that our 
morphological phenotype may be caused by a disruption in FGF signaling. Previous 
research has shown that blocking FGF signaling at the NMJ causes a disruption in 
synaptic clustering at nerve terminals (Fox et al., 2007). Since our LOF model exhibits no 
noticeable issues with vesicle clustering at the NMJ we can conclude that the ability for 
FGF signaling to induce vesicular clustering is intact. This provides indirect evidence that 
FGF-dependent transport at the NMJ is Erk1/2 independent.  
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Another class of trans-synaptic signaling factors that play a major role in the 
proper maturation of the NMJ are the laminins (Wu et al., 2010). Previous research has 
shown that the two main receptor complexes that basal lamina proteins bind to, integrins 
and dystroglycans, activate Erk/MAPK signaling (Spence et al., 2004; X. Wu, 2008). 
Mice lacking laminin at the NMJ showed a disruption in presynaptic differentiation of the 
NMJ (Fox et al., 2007). Since our LOF mouse model exhibits no noticeable problem with 
presynaptic morphology, we conclude that laminins at the NMJ do not require Erk1/2 for 
the development of presynaptic morphology. 
 GDNF/RET signaling is another component that is necessary for the proper 
maturation of the NMJ (Wu et al., 2010). Past research has shown that GDNF activates 
two signaling pathways: the MAPK pathway and the PI3 kinase (Trupp et al., 1999). It is 
plausible that abolishing Erk1/2 activity in the motor neuron may affect the efficacy of 
GDNF signaling through RET. Previous research has shown that a loss of proper GDNF 
signaling at the NMJ causes two distinct phenotypes (Baudet et al., 2008).  The first 
finding is that E18 embryos from RET knockout mutants exhibit developmentally 
delayed NMJs. The second finding is that adult NMJs from the Ret Nkx2.6:Cre model, 
which induces cre-mediated knockout of RET signaling in motor neurons, exhibit no 
structural abnormalities, but the total number of NMJs are reduced. Since the postnatal 
effects of RET deletion have not been studied it is unclear if they would exhibit a similar 
phenotype to that of the ChAT:Cre+/- , Erk1-\-, Erk2loxp/loxp, Ai9 +/- mouse model. It is 
possible that in our LOF model that NMJs are developmentally delayed due to improper 
GDNF/RET signaling and that if the mice lived into adulthood that some of the  
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developmentally delayed NMJs would mature while others would atrophy.  
 
Factors That Act on The Postsynaptic Membrane 
It is possible that the NMJs aren’t transitioning from plaque to pretzel due to a 
lack of a specific cue from the lower motor neuron. Previous research has shown that 
NMJs from mutant mice lacking ephexin1 fail to properly transition from plaque to 
pretzel (Shi et al., 2010). Ephexin1 is a downstream effector of EphA4 signaling which 
has been linked to actin cytoskeletal dynamics in the NMJ (Shi et al., 2010). Perhaps 
ephrin ligand expression is regulated by Erk1/2 activity in the lower motor neuron and 
could explain the morphological phenotype in our LOF model.  
Agrin is arguably the most important mediator of NMJ development. It is seen as 
a master organizer of the NMJ and mice that lack agrin fail to form NMJs and AChRs fail 
to properly cluster (Gautam et al., 1996). Given that our Erk1/2 LOF model forms 
synapses, albeit developmentally delayed, it is unlikely that agrin could be the source of 
our phenotype. However, previous research by Bolliger et al. 2010 has shown that 
specific proteolytic cleavage of agrin acts as a crucial regulatory step in the maturation of 
the NMJ (Bolliger et al., 2010). Bolliger et al. 2010 found that cleavage-resistant agrin in 
motor neurons caused developmentally delayed NMJs that appear similar to the NMJs in 
our Erk1/2 LOF model. There are two possibilities that can explain this phenotype. The 
first is that in the absence of Erk1/2 motor neurons are unable to produce a specific 
protease that can cleave agrin. Which specific protease that may be is unclear.  Bolliger et 
al. ruled out the possibility of neurotrypsin and MMP-3 as candidate proteases since NMJ  
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maturation occurs at a normal rate in the absence of these proteins. The second possibility 
is that Erk1/2 somehow mediate the cleavage of agrin itself. 
 
Chat:cre, CAMEK Gain-Of-Function Mouse Model 
Given the fact that the majority of the Rasopathies are caused by GOF mutations, 
it is crucial that we understand how upregulation of Erk/MAPK activity affects individual 
cell types (Rauen, 2013). Past research has shown that patients with Rasopathies 
frequently possess muscular defects (D. A. Stevenson & Yang, 2011).  Much of the 
research conducted on this subject has only investigated the role of Rasopathy mutations 
in the muscle itself, but not the motor neuron. Our research aimed to address whether an 
upregulation of Erk/MAPK activity in the lower motor neuron had any adverse affects on 
the proper development of the lower motor neuron.  
 
Cell survival and Activity in the Chat:Cre, CAMEK GOF Model 
  Just like the LOF model, the GOF model exhibited normal lower motor neuron 
survival. Also, just like the LOF model preliminary evidence suggests that levels of 
phosphorylated CREB are normal as well (not shown). Even though there is much 
evidence to support that Erk/MAPK plays an important role in activity dependent gene 
regulation and synaptic plasticity in other neuronal subtypes, it’s possible the that lower 
motor neurons don’t rely upon Erk/MAPK as heavily to accomplish these mechanisms. 
However, it’s also possible that phosphatases are able to detect an increase in Erk/MAPK 
activity and attenuate the high level signaling (Kondoh & Nishida, 2007). This prospect  
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seems more viable considering the phenotype we observed in the Erk1/2 LOF model.  
We hypothesized that the developmental delay observed in the Erk1/2 LOF model is due 
to a decrease in neuronal activity due to a downregulation of Erk-mediated AMPAR 
insertion in the lower motor neuron’s dendritic spines. If lower motor neurons truly do 
utilize Erk/MAPK signaling for activity-dependent gene regulation and synaptic 
plasticity, one would hypothesize that an unbalanced increase in Erk/MAPK signaling 
would lead to an increase in neuronal activity due to an upregulation of Erk-mediated 
AMPAR insertion in the lower motor neuron’s dendritic spines. The result of an increase 
in activity would be apparent in the process of NMJ maturation and axonal pruning. 
Since we didn’t observe acceleration in either of these processes it is possible that either 
phosphates regulate the increase in Erk/MAPK activity or the lower motor neuron doesn't 
heavily rely upon Erk/MAPK signaling. 
 
NMJ Maturation in the Chat:Cre, CAMEK GOF Model 
 Unlike the NMJs of the LOF model, the NMJs of the GOF model exhibit no 
obvious delays in maturation. The NMJs transition from plaque-to-pretzel at a normal 
rate, transition from poly-neuronal innervation to mono-neuronal innervation, and the 
morphology of both the presynaptic and postsynaptic aspect of the NMJ appear normal. 
Thus we can conclude that upregulating Erk/MAPK activity doesn’t affect the proper 
morphological maturation of the NMJ or the temporal dynamics of its activity-dependent 
maturation. 
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Behavioral Testing of the Chat:Cre, CAMEK GOF Model 
 Our analysis of the GOF mouse model led us to the conclusion that lower motor 
neuron development is unaffected by an upregulation of Erk/MAPK activity. This was a 
puzzling finding given the fact that we observed mild aberrant limb positioning in this 
mouse model. Since this phenotype couldn’t be explained by our histological analyses we 
executed several behavioral tests to more rigorously define this phenotype.   
The open field, rotarod, rope-climbing, and strength tests all resulted in negative 
findings. The behavioral assays showed no change in gross motor behavior, coordination, 
or strength. Since these findings produced no explanation for the mild behavioral 
phenotypes we observed in this mouse model, we decided to test for another aspect of 
behavior, spatial memory. 
 The Chat:cre CAMEK GOF model targets not only cholinergic lower motor 
neurons in the spinal cord, but also cholinergic neurons of the basal forebrain (Zaborszky 
et al., 2012). These cholinergic neurons play an distinct role in spatial memory (Okada et 
al., 2014). Preliminary evidence showed that in the GOF model these cholinergic neurons 
are intact (data not shown). Since this population of neurons was intact we predicted that 
there would be no difference in performance compared to litter mate controls in the 
watermaze behavioral assay. We found that the mice performed just as well as their age-
matched controls in spatial memory acquisition. Thus we can conclude that upregulating 
Erk/MAPK activity has no noticeable effect on spatial memory formation. 
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CHAPTER VI CONCLUSION 
 
Many Rasopathy patients exhibit abnormal muscular defects including hypotonia, 
decreased motor proficiency, decreased strength, variable muscle fiber size, and 
myopathy (Stevenson et al., 2012). Previous research has shown that these mutations 
arise from Erk/MAPK mutations in the muscle fibers. Whether these mutations can also 
arise from Erk/MAPK mutations in the motor neurons as well was unclear until now. The 
Erk1/2 GOF model that we generated exhibited normal lower motor neuron development 
and didn’t phenocopy any of the typical Rasopathy muscular deficits. We concluded that 
GOF Erk/MAPK mutations in the lower motor neurons are unlikely to cause the 
muscular abnormalities typically found in Rasopathy patients. However, the delay in 
morphological maturation observed in the NMJs of the LOF Erk/MAPK mouse model 
indicates some role of Erk/MAPK for the proper postnatal maturation of lower motor 
neurons. Further research needs to be done to elucidate how exactly Erk/MAPK activity 
regulates the proper postnatal development of the lower motor neuron. This research may 
provide valuable insight into why some neurons rely more heavily upon Erk/MAPK 
signaling than others. By elucidating how some neurons bypass the need for Erk/MAPK 
signaling, or rely less heavily upon it, we may be able to understand how to implement 
better treatment strategies for those who suffer from the neurological symptoms that arise 
from the neurons affected by Erk/MAPK mutations in Rasopathy patients.  
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